These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36990320)

  • 21. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old.
    Wolosker N; Schvartsman C; Krutman M; Campbell TP; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2014; 31(1):48-53. PubMed ID: 23627681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
    Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
    Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis.
    Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM
    Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Iyer S
    Dermatol Surg; 2002 Sep; 28(9):822-7. PubMed ID: 12269876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.
    Abels C; Soeberdt M; Kilic A; Reich H; Knie U; Jourdan C; Schramm K; Heimstaedt-Muskett S; Masur C; Szeimies RM
    Br J Dermatol; 2021 Aug; 185(2):315-322. PubMed ID: 33445205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
    Yokozeki H; Fujimoto T; Wanatabe S; Ogawa S; Fujii C
    J Dermatol; 2022 Jan; 49(1):86-94. PubMed ID: 34636057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise-induced sweating in healthy subjects as a model to predict a drug's sweat-reducing properties in hyperhydrosis: a prospective, placebo-controlled, double-blind study.
    Harmsze AM; Houte Mv; Deneer VH; Tupker RA
    Acta Derm Venereol; 2008; 88(2):108-12. PubMed ID: 18311434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, Safety and Quality of Life of Oxybutynin versus Aluminum Chloride Hexahydrate in Treating Primary Palmar Hyperhidrosis.
    Attallah HS; El-Gilany AH; Youssef YEB; Abdelshaheed ME; Sharaf EFA
    Indian J Dermatol; 2022; 67(3):222-227. PubMed ID: 36386101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
    Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
    Hebert AA; Glaser DA; Green L; Hull C; Cather J; Drew J; Gopalan R; Pariser DM
    Pediatr Dermatol; 2020 May; 37(3):490-497. PubMed ID: 32147881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production.
    Gregoriou S; Rigopoulos D; Makris M; Liakou A; Agiosofitou E; Stefanaki C; Kontochristopoulos G
    Dermatol Surg; 2010 Apr; 36(4):496-8. PubMed ID: 20180837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis.
    Chia HY; Tan AS; Chong WS; Tey HL
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1167-70. PubMed ID: 21812834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of endoscopic thoracic sympathectomy on sudomotor function in patients with palmar hyperhidrosis.
    Hirakawa N; Higashimoto I; Takamori A; Tsukamoto E; Uemura Y
    Clin Auton Res; 2021 Apr; 31(2):225-230. PubMed ID: 32342237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival study of treatment adherence by patients given oral oxibutynin for hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; García-Montero P; García-Harana C; Rivas Ruiz F; de Troya-Martín M
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1034-1037. PubMed ID: 29220103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxybutynin as an alternative treatment for hyperhidrosis.
    Delort S; Marchi E; Corrêa MA
    An Bras Dermatol; 2017; 92(2):217-220. PubMed ID: 28538882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
    Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
    Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
    Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis.
    El-Agamy El-Samadony A; Hegab DS; El Maghraby GM; El-Maadawy IH
    Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
    Kim WO; Kil HK; Yoon KB; Yoo JH
    Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.